نتائج البحث - Fabio Pellegrini

تنقيح النتائج
  1. 1
    The effectiveness of the Liverpool care pathway in improving end of life care for dying cancer patients in hospital. A cluster randomised trial

    The effectiveness of the Liverpool care pathway in improving end of life care for dying cancer patients in hospital. A cluster randomised trial حسب Massimo Costantini, Simona Ottonelli, Laura Canavacci, Fabio Pellegrini, Monica Beccaro

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Significant factors associated with fatal outcome in emergency open surgery for perforated peptic ulcer

    Significant factors associated with fatal outcome in emergency open surgery for perforated peptic ulcer حسب Mario Testini, Piero Portincasa, Giuseppe Piccinni, Germana Lissidini, Fabio Pellegrini, Luigi Greco

    منشور في 2003
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review

    Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review حسب Monica Franciosi, Giuseppe Lucisano, Emanuela Lapice, Giovanni FM Strippoli, Fabio Pellegrini, Antonio Nicolucci

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic Patients

    Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic Patients حسب Michele Sacco, Fabio Pellegrini, Maria Carla Roncaglioni, Fausto Avanzini, Gianni Tognoni, Antonio Nicolucci

    منشور في 2003
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery

    Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery حسب Luigi Tritapepe, Vincenzo De Santis, Domenico Vitale, Fabio Guarracino, Fabio Pellegrini, P Pietropaoli, Mervyn Singer

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry

    Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry حسب Stefan Braune, Sarah Grimm, Philip van Hövell, Ulrich Freudensprung, Fabio Pellegrini, Robert Hyde, Arnfin Bergmann

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease

    Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease حسب Suetonia C. Palmer, Jonathan C. Craig, Sankar D. Navaneethan, Marcello Tonelli, Fabio Pellegrini, Giovanni FM Strippoli

    منشور في 2012
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

    Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials حسب Giorgia De Berardis, Michele Sacco, Giovanni FM Strippoli, Fabio Pellegrini, Giusi Graziano, Gianni Tognoni, Antonio Nicolucci

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

    Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials حسب Giovanni FM Strippoli, Sankar D. Navaneethan, David W. Johnson, Vlado Perkovic, Fabio Pellegrini, Antonio Nicolucci, Jonathan C. Craig

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Identification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients

    Identification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients حسب Luigi Fontana, Filomena Addante, Massimiliano Copetti, Giulia Paroni, Andrea Fontana, Daniele Sancarlo, Fabio Pellegrini, Luigi Ferrucci, Alberto Pilotto

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results

    Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results حسب Helmut Butzkueven, Ludwig Kappos, Fabio Pellegrini, María Trojano, Heinz Wiendl, Ruchi Patel, A. Zhang, Christophe Hotermans, Shibeshih Belachew

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Cinacalcet in Patients with Chronic Kidney Disease: A Cumulative Meta-Analysis of Randomized Controlled Trials

    Cinacalcet in Patients with Chronic Kidney Disease: A Cumulative Meta-Analysis of Randomized Controlled Trials حسب Suetonia C. Palmer, Ionuţ Nistor, Jonathan C. Craig, Fabio Pellegrini, Piergiorgio Messa, Marcello Tonelli, Adrian Covic, Giovanni FM Strippoli

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    The Common −866G/A Polymorphism in the Promoter Region of the UCP-2 Gene Is Associated with Reduced Risk of Type 2 Diabetes in Caucasians from Italy

    The Common −866G/A Polymorphism in the Promoter Region of the UCP-2 Gene Is Associated with Reduced Risk of Type 2 Diabetes in Caucasians from Italy حسب Angela Bulotta, Ornella Ludovico, Angelo Coco, Rosa Di Paola, Alessandro Quattrone, Massimo Carella, Fabio Pellegrini, Sabrina Prudente, Vincenzo Trischitta

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

    Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) حسب Paul Knoebl, Pascual Marco, F. Baudo, Peter W. Collins, Angela Huth‐Kühne, László Nemes, Fabio Pellegrini, Lilian Tengborn, H. Lévesque

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

    Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) حسب Peter W. Collins, F. Baudo, Paul Knoebl, H. Lévesque, László Nemes, Fabio Pellegrini, Pascual Marco, Lilian Tengborn, Angela Huth‐Kühne

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

    Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry حسب F. Baudo, Peter W. Collins, Angela Huth‐Kühne, H. Lévesque, Pascual Marco, László Nemes, Fabio Pellegrini, Lilian Tengborn, Paul Knoebl

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance

    Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance حسب Monica Franciosi, Giorgia De Berardis, Maria Chiara Rossi, Michele Sacco, Maurizio Belfiglio, Fabio Pellegrini, Gianni Tognoni, Umberto Valentini, Antonio Nicolucci

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study

    Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study حسب Ludwig Kappos, Helmut Butzkueven, Heinz Wiendl, Timothy Spelman, Fabio Pellegrini, Yi Chen, Qunming Dong, Harold Koendgen, Shibeshih Belachew, María Trojano

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

    HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis حسب Sankar D. Navaneethan, Francesca Pansini, Vlado Perkovic, Carlo Manno, Fabio Pellegrini, David W. Johnson, Jonathan C. Craig, Giovanni FM Strippoli

    منشور في 2009
    احصل على النص الكامل
    Referência Bibliográfica
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Association between Resistin Levels and All-Cause and Cardiovascular Mortality: A New Study and a Systematic Review and Meta-Analysis

    Association between Resistin Levels and All-Cause and Cardiovascular Mortality: A New Study and a Systematic Review and Meta-Analysis حسب Andrea Fontana, Sara Spadaro, Massimiliano Copetti, Belinda Spoto, Lucia Salvemini, Patrizia Pizzini, Lucia Frittitta, Francesca Mallamaci, Fabio Pellegrini, Vincenzo Trischitta, Claudia Menzaghi

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: